UK-369,003
UK-369,003 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
4
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.
Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder
Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms
A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031
A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD
Clinical Trials (6)
Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.
Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder
Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms
A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031
A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD
Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile Dysfunction
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6